Literature DB >> 15778904

The receptor mechanism mediating the contractile response to adenosine on lung parenchymal strips from actively sensitised, allergen-challenged Brown Norway rats.

Cedric Wolber1, John R Fozard.   

Abstract

Parenchymal strips prepared from lungs removed from actively sensitised Brown Norway rats challenged with allergen show hyperresponsiveness to adenosine. The response is mast cell mediated and a preliminary pharmacological analysis suggested the involvement of a receptor (or receptors) that could not be classified as any of the known adenosine receptor subtypes. We present a further analysis of the response. Male Brown Norway (BN) rats, actively sensitised to ovalbumin (OA), were challenged intratracheally with OA and killed 3 h later to provide parenchymal strip preparations. The augmented contractile responses to adenosine were partially blocked by the 5-HT receptor antagonist, methysergide, or the A(1) receptor antagonist, DPCPX, and abolished in the presence of both antagonists. Responses to high concentrations of the A(1) receptor agonist, CPA were, like those to adenosine, augmented on tissues from allergen-challenged animals and blocked by a combination of methysergide and DPCPX. The A(3) receptor agonist, Cl-IB-MECA, did not contract the tissue, but partially blocked the response to adenosine. A combination of Cl-IB-MECA and methysergide induced a similar degree of blockade to that seen with either drug given alone. Combination of Cl-IB-MECA and/or methysergide with DPCPX abolished the response to adenosine. The effects of the A(3) receptor agonist, inosine, were augmented on tissues from allergen-challenged animals and markedly inhibited by disodium cromoglycate, methysergide or Cl-IB-MECA. Responses to adenosine were abolished when parenchymal strips were taken from rats pretreated 48 h previously with pertussis toxin. 8-SPT, CGS 15943, XAC, MRS 1754, DPCPX and theophylline, at concentrations which inhibit the A(1) A(2A) and/or A(2B) receptors but have negligible affinity for the rat A(3) receptor, inhibited responses to adenosine, but high concentrations were required and blockade was incomplete. MRS 1523 and MRS 1191, which are antagonists at the rat A(3) receptor, had no effect on the response to adenosine. The present results support and clarify our earlier conclusion that an atypical receptor mechanism mediates contraction of the parenchymal strip prepared from the lungs of actively sensitised BN rats challenged with allergen to adenosine. The response arises from a combined effect of adenosine on the A(1) receptor and a receptor with similarities to the A(3) receptor, but where Cl-IB-MECA behaves as an antagonist and MRS 1523 and MRS 1191 are inactive at concentrations that substantially exceed their affinities for the rat A(3) receptor.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15778904     DOI: 10.1007/s00210-004-1012-8

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  27 in total

1.  Antagonist pharmacology of adenosine A2B receptors from rat, guinea pig and dog.

Authors:  John R Fozard; Francois Baur; Cedric Wolber
Journal:  Eur J Pharmacol       Date:  2003-08-15       Impact factor: 4.432

2.  Derivatives of the triazoloquinazoline adenosine antagonist (CGS 15943) having high potency at the human A2B and A3 receptor subtypes.

Authors:  Y C Kim; M de Zwart; L Chang; S Moro; J K von Frijtag Drabbe Künzel; N Melman; A P IJzerman; K A Jacobson
Journal:  J Med Chem       Date:  1998-07-16       Impact factor: 7.446

3.  Effect of pertussis toxin treatment on the putative adenosine A3 receptor-mediated hypotensive response in the rat.

Authors:  A M Carruthers; J R Fozard
Journal:  Eur J Pharmacol       Date:  1993-11-30       Impact factor: 4.432

4.  Mechanism of airway hyperresponsiveness to adenosine induced by allergen challenge in actively sensitized Brown Norway rats.

Authors:  J P Hannon; B Tigani; I Williams; L Mazzoni; J R Fozard
Journal:  Br J Pharmacol       Date:  2001-04       Impact factor: 8.739

5.  Inosine binds to A3 adenosine receptors and stimulates mast cell degranulation.

Authors:  X Jin; R K Shepherd; B R Duling; J Linden
Journal:  J Clin Invest       Date:  1997-12-01       Impact factor: 14.808

6.  Evidence for an atypical receptor mediating the augmented bronchoconstrictor response to adenosine induced by allergen challenge in actively sensitized Brown Norway rats.

Authors:  J P Hannon; B Tigani; C Wolber; I Williams; L Mazzoni; C Howes; J R Fozard
Journal:  Br J Pharmacol       Date:  2002-02       Impact factor: 8.739

7.  Pharmacological responses of human and porcine lung parenchyma, bronchus and pulmonary artery.

Authors:  R G Goldie; J W Paterson; J L Wale
Journal:  Br J Pharmacol       Date:  1982-08       Impact factor: 8.739

Review 8.  Medicinal chemistry of adenosine A3 receptor ligands.

Authors:  Christa E Müller
Journal:  Curr Top Med Chem       Date:  2003       Impact factor: 3.295

9.  Airway hyperresponsiveness to bradykinin induced by allergen challenge in actively sensitised Brown Norway rats.

Authors:  K M Ellis; C Cannet; L Mazzoni; J R Fozard
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2004-01-15       Impact factor: 3.000

10.  Structural determinants of efficacy at A3 adenosine receptors: modification of the ribose moiety.

Authors:  Zhan-Guo Gao; Lak Shin Jeong; Hyung Ryong Moon; Hea Ok Kim; Won Jun Choi; Dae Hong Shin; Eleonora Elhalem; Maria J Comin; Neli Melman; Liaman Mamedova; Ariel S Gross; Juan B Rodriguez; Kenneth A Jacobson
Journal:  Biochem Pharmacol       Date:  2004-03-01       Impact factor: 5.858

View more
  6 in total

Review 1.  Adenosine signaling and the regulation of chronic lung disease.

Authors:  Yang Zhou; Daniel J Schneider; Michael R Blackburn
Journal:  Pharmacol Ther       Date:  2009-05-05       Impact factor: 12.310

2.  Control of enteric neuromuscular functions by purinergic A(3) receptors in normal rat distal colon and experimental bowel inflammation.

Authors:  L Antonioli; M Fornai; R Colucci; N Ghisu; M Tuccori; O Awwad; A Bin; C Zoppellaro; I Castagliuolo; R M Gaion; M C Giron; C Blandizzi
Journal:  Br J Pharmacol       Date:  2010-10       Impact factor: 8.739

3.  The Quintiles Prize Lecture 2004. The identification of the adenosine A2B receptor as a novel therapeutic target in asthma.

Authors:  Stephen T Holgate
Journal:  Br J Pharmacol       Date:  2005-08       Impact factor: 8.739

4.  Adenosine A(1) and prostaglandin E receptor 3 receptors mediate global airway contraction after local epithelial injury.

Authors:  Jian Zhou; Martha B Alvarez-Elizondo; Elliot Botvinick; Steven C George
Journal:  Am J Respir Cell Mol Biol       Date:  2012-12-06       Impact factor: 6.914

5.  Novel 2- and 4-substituted 1H-imidazo[4,5-c]quinolin-4-amine derivatives as allosteric modulators of the A3 adenosine receptor.

Authors:  Yoonkyung Kim; Sonia de Castro; Zhan-Guo Gao; Adriaan P Ijzerman; Kenneth A Jacobson
Journal:  J Med Chem       Date:  2009-04-09       Impact factor: 7.446

6.  Role of sphingosine-1-phosphate (S1P) and the S1P(2) receptor in allergen-induced, mast cell-dependent contraction of rat lung parenchymal strips.

Authors:  A Trifilieff; F Baur; J R Fozard
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2009-07-28       Impact factor: 3.000

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.